The pharmacogenetics of imanitib. - Wikidata - awgldk - TriplyDB

The pharmacogenetics of imanitib.

The pharmacogenetics of imanitib.

http://www.wikidata.org/entity/Q34469295

about

A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients.A rare case of osteonecrosis of the jaw related to imatinib Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia.hOCT1 gene expression predict for optimal response to Imatinib in Tunisian patients with chronic myeloid leukemia.Genetic variants in apoptosis-related genes associated with colorectal hyperplasia.Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients.Polycomb genes are associated with response to imatinib in chronic myeloid leukemia.Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia.A common novel splice variant of SLC22A1 (OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia.Do polymorphisms in MDR1 and CYP3A5 genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinib therapy?

P2860

Q33427392-C2E9BC98-3BC6-4959-8912-BB13DD7EEBC7 Q36360226-6E09A660-28BF-43B7-87C0-174FC7FDD2E6 Q38063197-F1A21DA0-8894-4CC2-953F-07D2AED65983 Q38902116-AD76978A-3D04-4774-BA15-6AEE8BEC69DA Q38991554-E8F9F2A5-6B90-414C-906C-2C8828A804AF Q39452105-982239CE-FFCA-4BD8-8296-F4D1F30C6068 Q41346071-A1E92EE0-FCE7-4564-95EA-185174E885F0 Q47216949-AA81610E-5FC1-4E54-B55D-1402944C921B Q54240000-194102E3-3E9E-4A07-8A3D-71E4A73D3AE3 Q55002373-27694209-2676-47B4-868B-755C71ABABA4

P2860

The pharmacogenetics of imanitib.

http://www.wikidata.org/entity/Q34469295

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The pharmacogenetics of imanitib.

@ast

The pharmacogenetics of imanitib.

@en

The pharmacogenetics of imanitib.

@nl

type

label

The pharmacogenetics of imanitib.

@ast

The pharmacogenetics of imanitib.

@en

The pharmacogenetics of imanitib.

@nl

prefLabel

The pharmacogenetics of imanitib.

@ast

The pharmacogenetics of imanitib.

@en

The pharmacogenetics of imanitib.

@nl

P1433

Q34469295-7675184D-0D32-4DEB-B42D-07BCDB64631D

P1476

Q34469295-C298639E-FA7D-4E3C-9E7A-C4FECD7F4125

P2093

Q34469295-81231FEB-1FA0-48AB-936D-A002D6FAB06F

Q34469295-D8DB77D1-8BF6-4288-A752-E80D8D62F244

P2860

Q34469295-07299660-DFE2-4C91-9D80-DE1ECA8561AB

Q34469295-0736AC36-422F-455A-A0AA-1A096DB5F92A

Q34469295-0BF0661F-7F01-4374-97F5-D4657B163A49

Q34469295-0F587E75-5272-4051-9772-C872D14611B2

Q34469295-186745B3-7758-44DE-94D0-84D1086572CC

Q34469295-1ADCC098-3F57-44F4-9EF7-361DD09F8D3D

Q34469295-1C42694F-CA14-480D-B135-12F39EA6A501

Q34469295-2A78ABF5-E549-4A7B-AF0D-CB97F9F27E9D

Q34469295-3F9FFEF7-07B7-4D64-98AF-7EDBDB0CDB70

Q34469295-40DD2EB4-E7FB-4E1E-B6C7-E4AC7E67FDF1

P2888

Q34469295-3150C0D8-75C1-4FAC-8227-3AB0CD7033EF

P304

Q34469295-323D7257-113B-4319-90B5-AF0D0C7A2A96

P31

Q34469295-ED1B3D9B-D460-4632-B716-E0D7159349DD

Q34469295-f02f4362-0088-4ed9-9ee1-b25b59f2b630

P356

Q34469295-1EAE73E2-E049-45F2-8C8C-3A658D7C4947

P433

Q34469295-AB299B2E-65A6-49C5-91E7-AF4EC16D6642

P478

Q34469295-358BDFEA-B9C1-4ECA-8026-B495C366D76D

P577

Q34469295-96B309FB-EC22-4919-915E-D64D49E47519

P5875

Q34469295-8B6585AC-5598-4BF0-8911-9CD47E3B4C8E

P6179

Q34469295-7706F189-CD25-402C-A8DA-2BC0D6D847E5

P698

Q34469295-9502EE7E-0F91-458C-B97D-6FF8649F1303

P932

Q34469295-CCFFBAAA-2CCA-43A4-B083-0652E4ABC9CF

P356

P1433

Genome Medicine

P1476

The pharmacogenetics of imanitib.

@en

P2093

Maja Krajinovic

http://www.w3.org/2001/XMLSchema#string

Stéphanie Dulucq

http://www.w3.org/2001/XMLSchema#string

P2860

Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1

Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences

A "silent" polymorphism in the MDR1 gene changes substrate specificity

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

Active transport of imatinib into and out of cells: implications for drug resistance.

Correlation of major cytogenetic response with a pharmacogenetic marker in chronic myeloid leukemia patients treated with imatinib (STI571).

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

P2888

P304

85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/GM206

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49649425

http://www.w3.org/2001/XMLSchema#string

P6179

1047302154

http://www.w3.org/2001/XMLSchema#string

P698

21122163

http://www.w3.org/2001/XMLSchema#string

P932

3016627

http://www.w3.org/2001/XMLSchema#string